Isatuximab-ifrc is the third monoclonal antibody approved for the treatment of R/R MM.
Frances R. Blevins, PA-C
Advertisement
Articles by Frances R. Blevins, PA-C
Advertisement
Latest Updated Articles
A New Monoclonal Antibody for R/R MM: Isatuximab-irfcPublished: July 30th 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Dato-DXd Doubles Response Rates and Extends Survival in First-Line Metastatic TNBC
2
Emerging Biomarkers Open New Frontiers in Lung Cancer Therapy
3
Final EMBARK Data Show “Almost Unprecedented” Reduction in Risk of Death With Enzalutamide Plus ADT in Biochemically Recurrent Prostate Cancer
4
Weekly Paclitaxel May Hold the Key to Pembrolizumab’s Success in Platinum-Resistance Ovarian Cancer
5
